Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma

Zhou, J., Wu, Z., Zhang, Z., Goss, L., McFarland, J., Nagaraja, A., Xie, Y., Gu, S., Peng, K., Zeng, Y., Zhang, X., Long, H., Nakagawa, H., Rustgi, A., Diehl, J. A., Meyerson, M., Wong, K.-K., & Bass, A. (2021). Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma. Gut, 71(4), 665–675. https://doi.org/10.1136/gutjnl-2020-323276
Authors:
Jin Zhou
Zhong Wu
Zhouwei Zhang
Louisa Goss
James McFarland
Ankur Nagaraja
Yingtian Xie
Shengqing Gu
Ke Peng
Yong Zeng
Xiaoyang Zhang
Henry Long
Hiroshi Nakagawa
Anil Rustgi
J Alan Diehl
Matthew Meyerson
Kwok-Kin Wong
Adam Bass
Affiliated Authors:
Hiroshi Nakagawa
Anil Rustgi
Adam Bass
Author Keywords:
cell cycle control
oesophageal cancer
pharmacogenomics
pharmacotherapy
Publication Type:
Article
Unique ID:
10.1136/gutjnl-2020-323276
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: